A, T., G, L., V, D., L, P., S, M., & A, S. (2020). Impact of 68Ga-DOTATOC PET/CT in comparison to 111In-Octreotide SPECT/CT in management of neuro-endocrine tumors: A case report. Medicine, 99(7), e19162. https://doi.org/10.1097/MD.0000000000019162
Chicago Style (17th ed.) CitationA, Tolomeo, Lopopolo G, Dimiccoli V, Perioli L, Modoni S, and Scilimati A. "Impact of 68Ga-DOTATOC PET/CT in Comparison to 111In-Octreotide SPECT/CT in Management of Neuro-endocrine Tumors: A Case Report." Medicine 99, no. 7 (2020): e19162. https://doi.org/10.1097/MD.0000000000019162.
MLA (9th ed.) CitationA, Tolomeo, et al. "Impact of 68Ga-DOTATOC PET/CT in Comparison to 111In-Octreotide SPECT/CT in Management of Neuro-endocrine Tumors: A Case Report." Medicine, vol. 99, no. 7, 2020, p. e19162, https://doi.org/10.1097/MD.0000000000019162.